US 11612652
Lipids as synthetic vectors to enhance antigen processing and presentation ex-vivo in dendritic cell therapy
granted A61KA61K2039/55505A61K2039/55522
Quick answer
US patent 11612652 (Lipids as synthetic vectors to enhance antigen processing and presentation ex-vivo in dendritic cell therapy) held by PDS Biotechnology Corporation expires Mon Mar 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- PDS Biotechnology Corporation
- Grant date
- Tue Mar 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K2039/55505, A61K2039/55522, A61K2039/55555, A61K2039/55572